This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB02239/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02239/identifier/pubchem-compound/
n16http://linked.opendata.cz/resource/drugbank/drug/DB02239/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02239/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02239/identifier/chemspider/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/resource/drugbank/drug/DB02239/identifier/chebi/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB02239/identifier/wikipedia/

Statements

Subject Item
n2:DB02239
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB02239 n14:DB02239
dcterms:title
Laevulinic Acid
adms:identifier
n5:39149 n10:SHF n11:11579 n12:11091 n13:DB02239 n15:Laevulinic_Acid n16:46504792
n3:synthesisReference
Bernard Capai, Guy Lartigau, "Preparation of laevulinic acid." U.S. Patent US5175358, issued December, 1939.
n3:IUPAC-Name
n7:271B4ABF-363D-11E5-9242-09173F13E4C5
n3:InChI
n7:271B4AC5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n7:271B4AC4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n7:271B4AC1-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n7:271B4AC2-363D-11E5-9242-09173F13E4C5
n3:SMILES
n7:271B4AC3-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n7:271B4ABD-363D-11E5-9242-09173F13E4C5
n3:logP
n7:271B4AD7-363D-11E5-9242-09173F13E4C5 n7:271B4ABB-363D-11E5-9242-09173F13E4C5 n7:271B4ABE-363D-11E5-9242-09173F13E4C5
n3:logS
n7:271B4ABC-363D-11E5-9242-09173F13E4C5
n3:pKa
n7:271B4AD8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n7:271B4ACB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n7:271B4ACC-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n7:271B4AC6-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n7:271B4AC7-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n7:271B4AC9-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n7:271B4AC8-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n7:271B4ACA-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
123-76-2
n3:Bioavailability
n7:271B4AD1-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n7:271B4AD6-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n7:271B4AD3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n7:271B4AD4-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n7:271B4AD5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n7:271B4AD0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n7:271B4ACF-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n7:271B4AD2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n7:271B4AC0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n7:271B4ACD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n7:271B4ACE-363D-11E5-9242-09173F13E4C5